Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) shares are trading higher Monday after the company announced it entered into a ...

Citius Pharmaceuticals Inc (NASDAQ: CTXR ), the parent company of Citius Oncology, also saw its shares climb by 6.7%. Meanwhile, Cardinal Health’s stock remained flat after the news.

CITIUS ONCOLOGY, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE SIX MONTHS ENDED MARCH 31, 2025 AND 2024 (Unaudited) 2025 2024 Cash Flows From Operating Activities: Net loss ...

The newly combined public company will continue to trade on the Nasdaq stock exchange and is to be renamed Citius Oncology, Inc. ("Citius Oncology"). The transaction has been unanimously approved ...

Citius Oncology inks distribution services agreement with Cardinal Health: Cranford, New Jersey Wednesday, June 11, 2025, 11:00 Hrs [IST] Citius Oncology, Inc. (Citius Oncology), ...

These 10 undervalued real estate stocks pay dividends and trade at attractive prices. We sell different types of products and services to both investment professionals and individual investors ...

Citius Oncology (NASDAQ:CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals (NASDAQ:CTXR), has entered into a distribution services agreement with Cardinal Health (NYSE:CAH). This ...